BOLT insider transactions
Bolt Biotherapeutics Inc. (BOLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
BOLT insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Bolt Biotherapeutics Inc., latest first. Follow anyone to get their next filing.
- Grant YonehiroChief Operating Officer+$9,010-$43.8K
- Sarah NemecSenior VP, Finance and PAO, since May 2024+$6,070-$26.1K
- William P. QuinnPresident, CEO and CFO, Director+$68.1K-$58.4K
- Jakob DupontDirector, since September 2024
- Nicole OnettoDirector, since December 2021
- Laura BernerDirector, since December 2022
- Kathleen LaporteDirector
- Brian O'CallaghanDirector, since November 2021
- Mahendra ShahDirector
- Frank D. LeeDirector, since November 2021
- James HealyDirector
- Edith A. PerezChief Medical Officer+$28.6K
- Randall C SchatzmanChief Executive Officer, Director+$12K
- Edgar EnglemanDirector-$176K
- Vivo Capital VIII, LLC10% owner-$83K
- Miller Richard A MdDirector
- Novo Holdings A/S10% owner-$1.6M
- David DornanOfficer
Recent Form 3, 4, and 5 filings for BOLT
- SEC Form 3 filed by Bolt Biotherapeutics Inc.3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Bolt Biotherapeutics Inc.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 3 filed by Bolt Biotherapeutics Inc.3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- President, CEO and CFO Quinn William P. bought $2,469 worth of shares (637 units at $3.88) and sold $58,402 worth of shares (17,566 units at $3.32), increasing direct ownership by 997% to 25,384 units (SEC Form 4) to satisfy withholding tax4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Senior VP, Finance and PAO Nemec Sarah bought $1,973 worth of shares (509 units at $3.88) and sold $26,072 worth of shares (7,842 units at $3.32), increasing direct ownership by 1,107% to 17,082 units (SEC Form 4) to satisfy withholding tax4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Chief Operating Officer Yonehiro Grant sold $43,807 worth of shares (13,176 units at $3.32), decreasing direct ownership by 43% to 17,269 units (SEC Form 4) to satisfy tax liability4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- President, CEO and CFO Quinn William P. bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 6% to 2,313 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Yonehiro Grant4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Senior VP, Finance and PAO Nemec Sarah bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 10% to 1,415 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Dupont Jakob4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Onetto Nicole4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Berner Laura4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Laporte Kathleen4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director O'Callaghan Brian4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Senior VP, Finance and PAO Nemec Sarah4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Yonehiro Grant4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by President, CEO and CFO Quinn William P.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Senior VP, Finance and PAO Nemec Sarah was granted 23,000 shares and bought $686 worth of shares (125 units at $5.49), increasing direct ownership by 2,827% to 23,943 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Chief Operating Officer Yonehiro Grant was granted 30,000 shares, increasing direct ownership by 336% to 38,918 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- President, CEO and CFO Quinn William P. bought $686 worth of shares (125 units at $5.49) and was granted 40,000 shares, increasing direct ownership by 1,945% to 42,188 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Dupont Jakob4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Berner Laura4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Onetto Nicole4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Laporte Kathleen4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director O'Callaghan Brian4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Dupont Jakob4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Yonehiro Grant4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Senior VP, Finance and PAO Nemec Sarah bought $2,835 worth of shares (5,000 units at $0.57), decreasing direct ownership by 2% to 13,863 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- President, CEO and CFO Quinn William P. bought $2,835 worth of shares (5,000 units at $0.57) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Dupont Jakob4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 3 filed by new insider Dupont Jakob3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Yonehiro Grant4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by President, CEO and CFO Quinn William P.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by VP, Finance and PAO Nemec Sarah4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Shah Mahendra4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Onetto Nicole4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director O'Callaghan Brian4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Lee Frank D.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Laporte Kathleen4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Healy James4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Director Berner Laura4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- New insider Nemec Sarah claimed ownership of 11,363 shares (SEC Form 3)3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Yonehiro Grant4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Perez Edith A.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Schatzman Randall C4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Quinn William P.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Yonehiro Grant bought $1,955 worth of shares (2,500 units at $0.78), increasing direct ownership by 39% to 8,918 units (SEC Form 5)5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Perez Edith A. bought $4,401 worth of shares (4,570 units at $0.96), increasing direct ownership by 11% to 46,612 units (SEC Form 5)5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Schatzman Randall C bought $4,909 worth of shares (5,000 units at $0.98), increasing direct ownership by 64% to 12,859 units (SEC Form 5)5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Quinn William P. bought $11,241 worth of shares (11,829 units at $0.95), increasing direct ownership by 48% to 36,272 units (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Engleman Edgar sold $128,993 worth of shares (148,884 units at $0.87) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Engleman Edgar sold $1,751 worth of shares (1,943 units at $0.90) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Vivo Capital Viii, Llc sold $3,060 worth of shares (3,400 units at $0.90) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Engleman Edgar sold $45,675 worth of shares (49,173 units at $0.93) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- Vivo Capital Viii, Llc sold $7,636 worth of Comon Stock (8,211 units at $0.93) and sold $72,297 worth of shares (77,843 units at $0.93) (SEC Form 4)4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Shah Mahendra4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Onetto Nicole4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by O'Callaghan Brian4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Miller Richard A Md4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
- SEC Form 4 filed by Lee Frank D.4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)